Page last updated: 2024-11-02

phenylbutazone and Lupus Erythematosus, Discoid

phenylbutazone has been researched along with Lupus Erythematosus, Discoid in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Lupus Erythematosus, Discoid: A chronic form of cutaneous lupus erythematosus (LUPUS ERYTHEMATOSUS, CUTANEOUS) in which the skin lesions mimic those of the systemic form but in which systemic signs are rare. It is characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy. Lesions are surrounded by an elevated erythematous border. The condition typically involves the face and scalp, but widespread dissemination may occur.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maintz, J1
Henningsen, B1
Buchholz, K1
Harders, H1

Other Studies

1 other study available for phenylbutazone and Lupus Erythematosus, Discoid

ArticleYear
[Unusual clinical forms of pseudo-LE syndrome: an induced immune-complex disease? (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1975, Jul-25, Volume: 100, Issue:30

    Topics: Adult; Aged; Antibodies; Bone Marrow Diseases; Female; Humans; Immune Complex Diseases; Lupus Erythe

1975